Latest Sevelamer Stories
EXTON, Pa., July 15 /PRNewswire/ -- BioTrends Research Group, Inc. has released two new syndicated market research reports evaluating the nephrology market in Europe.
MORRISTOWN, N.J., May 25 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc. filed an Abbreviated New Drug Application (ANDA) with the U.S.
EXTON, Pa., April 29 /PRNewswire/ -- BioTrends Research Group, Inc. recently published two syndicated reports focused on the management of bone and mineral metabolism in the US.
EXTON, Pa., Jan. 7 /PRNewswire/ -- BioTrends Research Group, Inc. recently released its TreatmentTrendsÂ®: US Nephrology, EU Nephrology, and Canadian Nephrology publications. Each syndicated report offers comprehensive insight into the management of bone and mineral metabolism.
DUBLIN, October 7 /PRNewswire-FirstCall/ -- - For Medical and Healthcare Media Only - - Direct Comparison of the Two non-Calcium Phosphate Binders Gives new Insights Into Relative Efficacy Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announces the publication in Clinical Nephrology of findings from a head-to-head clinical study comparing the efficacy of two non-calcium based phosphate binders, FOSRENOL(R) (lanthanum carbonate) and...
NEW YORK, June 8 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc.
EXTON, Pa., April 30 /PRNewswire/ -- BioTrends Research Group, Inc. released ChartTrends(R): Bone and Mineral Metabolism in Dialysis, a syndicated publication offering comprehensive insight into the management of calcium, phosphorus and PTH in dialysis patients.
EXTON, Pa., April 27 /PRNewswire/ -- BioTrends Research Group, Inc.
EXTON, Pa., May 6 /PRNewswire-FirstCall/ -- BioTrends Research Group, Inc.
CAMBRIDGE, Mass., March 6 /PRNewswire-FirstCall/ -- Genzyme Corp. today announced the U.S. launch of the phosphate binder Renvela(R) (sevelamer carbonate) for dialysis patients, as well as significant progress in its international efforts to secure additional approvals for the product.